These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 29438119)

  • 1. Liver disease in patients with cystic fibrosis.
    Kamal N; Surana P; Koh C
    Curr Opin Gastroenterol; 2018 May; 34(3):146-151. PubMed ID: 29438119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis, follow-up and treatment of cystic fibrosis-related liver disease.
    van de Peppel IP; Bertolini A; Jonker JW; Bodewes FAJA; Verkade HJ
    Curr Opin Pulm Med; 2017 Nov; 23(6):562-569. PubMed ID: 28837442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic manifestations of cystic fibrosis.
    Dana J; Girard M; Debray D
    Curr Opin Gastroenterol; 2020 May; 36(3):192-198. PubMed ID: 32097175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic Manifestations of Cystic Fibrosis.
    Sakiani S; Kleiner DE; Heller T; Koh C
    Clin Liver Dis; 2019 May; 23(2):263-277. PubMed ID: 30947876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Treatment Options for Cystic Fibrosis-Related Liver Disease.
    Staufer K
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic fibrosis-related liver disease: Clinical presentations, diagnostic and monitoring approaches in the era of CFTR modulator therapies.
    Dana J; Debray D; Beaufrère A; Hillaire S; Fabre M; Reinhold C; Baumert TF; Berteloot L; Vilgrain V
    J Hepatol; 2022 Feb; 76(2):420-434. PubMed ID: 34678405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of Cystic Fibrosis Liver Disease: A Channelopathy Leading to Alterations in Innate Immunity and in Microbiota.
    Fiorotto R; Strazzabosco M
    Cell Mol Gastroenterol Hepatol; 2019; 8(2):197-207. PubMed ID: 31075352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging clinical perspectives in cystic fibrosis liver disease.
    Athwal VS; Scott JA; Fitzpatrick E; Rowland M
    Curr Opin Pulm Med; 2021 Nov; 27(6):593-599. PubMed ID: 34482340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic Fibrosis-related Liver Disease: Research Challenges and Future Perspectives.
    Debray D; Narkewicz MR; Bodewes FAJA; Colombo C; Housset C; de Jonge HR; Jonker JW; Kelly DA; Ling SC; Poynard T; Sogni P; Trauner M; Witters P; Baumann U; Wilschanski M; Verkade HJ
    J Pediatr Gastroenterol Nutr; 2017 Oct; 65(4):443-448. PubMed ID: 28753176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The natural history of cystic fibrosis liver disease a prospective cohort study.
    Rowland M; Drummond J; Connolly L; Daly E; McCormick PA; Bourke B; ;
    J Cyst Fibros; 2023 Nov; 22(6):1054-1061. PubMed ID: 37495468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal, Pancreatic, and Hepatobiliary Manifestations of Cystic Fibrosis.
    Sathe MN; Freeman AJ
    Pediatr Clin North Am; 2016 Aug; 63(4):679-98. PubMed ID: 27469182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic Fibrosis Liver Disease: Know More.
    Al Sinani S; Al-Mulaabed S; Al Naamani K; Sultan R
    Oman Med J; 2019 Nov; 34(6):482-489. PubMed ID: 31745411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: epidemiology, pathogenesis and management of liver disease in adults with cystic fibrosis.
    Scott J; Jones AM; Piper Hanley K; Athwal VS
    Aliment Pharmacol Ther; 2022 Feb; 55(4):389-400. PubMed ID: 35048397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic fibrosis related liver disease and endocrine considerations.
    Sherwood JS; Ullal J; Kutney K; Hughan KS
    J Clin Transl Endocrinol; 2022 Mar; 27():100283. PubMed ID: 35024343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models for cystic fibrosis liver disease (CFLD).
    Fiorotto R; Amenduni M; Mariotti V; Cadamuro M; Fabris L; Spirli C; Strazzabosco M
    Biochim Biophys Acta Mol Basis Dis; 2019 May; 1865(5):965-969. PubMed ID: 30071276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and characteristics of cystic fibrosis liver disease: a study highlighting the lack of histological diagnosis.
    Issa Z; Gohy S; Zech F; Baldin P; Delire B; Dahlqvist G
    Clin Res Hepatol Gastroenterol; 2022 Nov; 46(9):101977. PubMed ID: 35772685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatobiliary complications of cystic fibrosis.
    Feranchak AP
    Curr Gastroenterol Rep; 2004 Jun; 6(3):231-9. PubMed ID: 15128491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic fibrosis-associated liver disease in children.
    Wasuwanich P; Karnsakul W
    Minerva Pediatr; 2020 Oct; 72(5):440-447. PubMed ID: 32418413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic fibrosis related liver disease--another black box in hepatology.
    Staufer K; Halilbasic E; Trauner M; Kazemi-Shirazi L
    Int J Mol Sci; 2014 Aug; 15(8):13529-49. PubMed ID: 25093717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of a large cohort of cystic fibrosis patients with severe liver disease indicates lung function decline does not significantly differ from that of the general cystic fibrosis population.
    Polineni D; Piccorelli AV; Hannah WB; Dalrymple SN; Pace RG; Durie PR; Ling SC; Knowles MR; Stonebraker JR
    PLoS One; 2018; 13(10):e0205257. PubMed ID: 30307979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.